Company · CAI
Caris Life Sciences, Inc.
Nasdaq's symbol directory lists CAI on Nasdaq as “Caris Life Sciences, Inc. - Common Stock”.
In the 12 months to Nov 8, 2026: insiders bought on 1 occasion ($990K); insiders sold on 4 occasions ($27.2M); 2 planned-sale notices; 3 filings by holders of 5% or more; 2 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Spetzler David Baxley, President sold $14.8M
- Brille Brian J, Vice Chairman and Executive Vice President sold $12.1M
- HALBERT JON bought $990K
- Denton John Russel, Senior Vice President, General Counsel, and Secretary sold $239K
Every trade (5)
- SELLDenton John Russel, Senior Vice President, General Counsel, and Secretary sold $239K
- SELLBrille Brian J, Vice Chairman and Executive Vice President sold $12.1M
- SELLSpetzler David Baxley, President sold $3.0M
- SELLSpetzler David Baxley, President sold $11.9M
- BUYHALBERT JON bought $990K
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- JOHN RUSSEL DENTON $239K
- BRIAN J BRILLE $12.1M
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- FMR LLC 13.4%
- J H Whitney VI L P 4%
- TSSP Sub-Fund HoldCo LLC 2.4%
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Results of operations and financial condition Nov 4, 2026
- Regulation FD disclosure Sep 14, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.